Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 243 Neoplasms 17 Neoplasm Metastasis 15 Carcinoma, Intraductal, Noninfiltrating 11 Breast Diseases 8 Advanced Breast Cancer 8 Breast Neoplasms, Male 7 Breast Carcinoma In Situ 7 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Arthralgia 5 Neoplasms by Site 3 Breast Cancer Metastatic 3 Uterine Cervical Neoplasms 2 Recurrence 2 Patient Compliance 2 Osteoporosis 2 Obesity 2 Multiple Endocrine Neoplasia Type 1 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasm Female 2 Vitamin D Deficiency 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1

Interventions

Zoledronic Acid 6 Risedronic Acid 5 Calcium 4 Vitamin D 3 Denosumab 3 Letrozole 2 Toremifene 1 Radiography, Panoramic 1 Nutrition Assessment 1 Kyphoplasty 1 Ibandronic Acid 1 Health Promotion 1 Geritol 1 Exercise Movement Techniques 1 Exercise 1 Cholecalciferol 1 Calcium Carbonate 1 Aromatase Inhibitors 1 Anastrozole 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases, Metabolic × Anastrozole × Clear all

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡